Aleksandra Okońska

Aleksandra Okońska

Auto-generated profile, based on publicly available information

Aleksandra Okońska

University Clinical Hospital in Bialystok ul. M. C. Skłodowskiej 24a, 15-276 Białystok, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AOAleksandra Okońska
Aleksandra Okońska
DHDominika Hakało
Dominika Hakało
MIMarta Ignatiuk-Chilkiewicz
Marta Ignatiuk-Chilkiewicz
JKJoanna Kałuska
Joanna Kałuska
WJWeronika Jelska
Weronika Jelska
MKMagdalena Kiślak
Magdalena Kiślak
Introduction: This study aims to analyze the risk factors associated with depression in adolescents, focusing on the interplay between biological, psychological, and social determinants. Materials and methods: A review of chosen literature from PubMed, and Google Scholar was conducted, using key words including "depression", "adolescence", "stress", "mental health". Summary: Depression in adolescents is strongly associated with significant biological changes, including hormonal shifts, and neural maturation. Gender differences are particularly prominent, with girls showing higher prevalence and severity of depressive symptoms due to factors such as hormonal sensitivity to stress, and genetic variance. Family and interpersonal relationships also play a role, as parental depression, low parental warmth, high criticism, and peer rejection increase the risk of depression. Conversely, positive family dynamics and supportive peer relationships act as protective factors. Sleep disturbances were found to have a profound impact on adolescent mental health. Delayed circadian rhythms, and poor sleep hygiene are linked to increased depressive symptoms. Stressful life events emerged as significant environmental risk factors, with maladaptive coping strategies exacerbating vulnerability. The study underscores the critical mediating role of perceived social support in mitigating the effects of stress on mental health. Conclusions: The findings of this study highlight the need for integrated strategies to address adolescent depression. Interventions should include early detection programs, gender-sensitive approaches, and family-based therapies to foster supportive relationships. Given that depression during adolescence often tracks into adulthood and increases the risk of recurrent episodes and suicidality, targeted efforts during this developmental phase are paramount.

17 March 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
WGWeronika Barbara Grywińska
Weronika Barbara Grywińska
AOAleksandra Okońska
Aleksandra Okońska
JKJulia Kozakiewicz
Julia Kozakiewicz
KKKamil Kościelecki
Kamil Kościelecki
AKAgnieszka Kalisz
Agnieszka Kalisz
AGAleksandra Głowacka
Aleksandra Głowacka
Introduction: Eating disorders (EDs) are complex mental health conditions with significant treatment barriers, including stigma and limited access to care. Virtual reality (VR) offers a novel approach by providing immersive, controlled environments for addressing body image concerns and maladaptive eating behaviours. This review explores VR’s potential in ED treatment based on recent research. Methods: A literature review was conducted using PubMed, Google Scholar, and Web of Science, focusing on studies from the past five years that examined VR as a treatment tool. Clinical outcomes, intervention types, and methodologies were analysed. Summary of Findings: VR has shown promise in reducing body dissatisfaction, fear of weight gain, and binge eating behaviours. Studies using personalized avatars, attentional bias training, and exposure therapy demonstrated improvements in body image perception, anxiety reduction, and coping skills. VR-enhanced cognitive behavioural therapy (VR-CBT) was particularly effective for bulimia nervosa and binge eating disorder. Conclusions: VR is an effective, accessible tool for ED treatment, offering safe and engaging therapeutic experiences. While promising, further research is needed to refine treatment protocols and enhance personalization. As technology advances, VR has the potential to bridge treatment gaps and improve ED recovery outcomes.

7 April 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ISIwona Skorulska
Iwona Skorulska
PGPaulina Grzeszczuk
Paulina Grzeszczuk
AGAleksandra Głowacka
Aleksandra Głowacka
JKJulia Kozakiewicz
Julia Kozakiewicz
AOAleksandra Okońska
Aleksandra Okońska
AKAgnieszka Kalisz
Agnieszka Kalisz
Introduction: This review paper aims to systematize the current knowledge about Mondor's disease, its etiology and epidemiology, diagnostic methods, differential diagnosis, and therapeutic approaches. Furthermore, it examines the prognosis and potential complications based on a comprehensive review of the available literature. Materials and methods: A review of selected literature in the PubMed database was conducted, using the following keywords: ,,Mondor’s disease”, ,,vein thrombosis”, ,,superficial thrombophlebitis”. Summary: Mondor’s disease is a rare, self-limiting superficial thrombophlebitis, primarily affecting the anterior chest wall but also documented in the abdomen, axilla, groin, and penis. Its etiology remains unclear, though mechanical stress, inflammation, and hypercoagulability are implicated. It predominantly affects middle-aged women. Though benign, its clinical presentation may mimic malignancies, causing significant distress.Diagnosis is primarily clinical, based on a palpable, tender, cord-like structure without systemic symptoms. Imaging, particularly ultrasonography, is warranted when malignancy is suspected. Mammography or Magnetic Resonance Imaging may be used to exclude neoplastic conditions.Management is conservative, focusing on NSAIDs, topical therapies, and activity modification. Anticoagulation is generally unnecessary but may be considered in extensive thrombosis. Surgical intervention is rare. Prognosis is favorable, with spontaneous resolution within weeks, though secondary cases require treatment of the underlying condition. Conclusions: Healthcare providers must recognize Mondor’s disease to ensure accurate diagnosis and effective management. While conservative treatment remains the standard, further research into its pathophysiology may refine diagnostic and therapeutic strategies. In recurrent or secondary cases, vigilance for thrombotic disorders or malignancies is essential for comprehensive patient care.

7 April 2025 in Quality in Sport
Verified
Journal Article
Open access
KKKamil Kościelecki
Kamil Kościelecki
AKAgnieszka Kalisz
Agnieszka Kalisz
AOAleksandra Okońska
Aleksandra Okońska
JKJulia Kozakiewicz
Julia Kozakiewicz
ISIwona Skorulska
Iwona Skorulska
KMKlaudia Mączewska
Klaudia Mączewska
Introduction: This review paper aims to emphasize how Alpha-1-antitrypsin deficiency is how can lead to serious disease states, indicating the pathophysiology, symptoms, diagnostic possibilities, therapeutic methods and proving that early diagnostics for this deficiency can protect the patient from its serious consequences Materials and methods: A review of chosen literature in the PubMed database was conducted, using the following keywords: „Alpha-1-antitrypsin deficiency”, „Alpha-1-antitrypsin” Summary: Alpha-1-antitrypsin deficiency is a relatively common condition that is often overlooked in diagnostic evaluations. It can lead to serious health complications, substantially reduce quality of life, and even shorten a patient's lifespan. Early diagnosis is essential because it allows for the adoption of healthier lifestyle habits and more consistent health monitoring, which can help mitigate the condition’s long-term consequences. Conclusions: Symptoms of alpha-1 antitrypsin deficiency are quite prevalent and can affect individuals across all age groups—from infants and children to adults and the elderly. This deficiency may lead to serious complications, including COPD, emphysema, asthma, liver cirrhosis, hepatocellular carcinoma (HCC). A deep understanding of its pathophysiology has enabled the development of improved diagnostic techniques and novel treatment strategies. For instance, in young adults with COPD and children exhibiting signs of liver disease, it is advisable to measure alpha-1 antitrypsin levels or perform genotyping. In cases where a significant deficiency is detected, initiating replacement therapy and closely monitoring the patient's health is crucial.

8 March 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JKJulia Kozakiewicz
Julia Kozakiewicz
AOAleksandra Okońska
Aleksandra Okońska
KKKamil Kościelecki
Kamil Kościelecki
AKAgnieszka Kalisz
Agnieszka Kalisz
KMKlaudia Mączewska
Klaudia Mączewska
PGPaulina Grzeszczuk
Paulina Grzeszczuk
Introduction: This review paper aims to emphasize how pulmonary embolism is a seriously life-threatening disease entity, point out risk factors, symptoms, diagnostic trails, treatment and prove that a diagnosis, specifically aimed at embolism is often not obvious in given clinical cases. Materials and methods: A review of chosen literature in the PubMed database was conducted, using the following keywords: ,, pulmonary embolism”, ,,vein thrombosis’’, ,,thrombosis risk factors”, ,,anticoagulation”. Summary: Pulmonary embolism is a dangerous disease that can lead to serious complications and death, if not properly diagnosed and treated. Proper diagnosis is crucial, as symptoms can be uncharacteristic and embolism can occur in a variety of configurations. Prompt implementation of treatment, including the use of anticoagulants, as well as appropriate medical care, can significantly improve patients' prognosis. Conclusions: Lesser-known risk factors for pulmonary embolism include sepsis, urinary retention, hematologic, rheumatic and endocrine diseases, organ transplants, treatment with bone cement or tranexamic acid. It is important to conduct diagnostic testing for pulmonary embolism when characteristic symptoms occur and introduce appropriate therapy as well as thromboprophylaxis depending on the patient's risk and clinical condition.

27 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JKJulia Kozakiewicz
Julia Kozakiewicz
AOAleksandra Okońska
Aleksandra Okońska
MZMichał Ziemba
Michał Ziemba
KKKamil Kościelecki
Kamil Kościelecki
AKAgnieszka Kalisz
Agnieszka Kalisz
AKAleksandra Kaczmarek
Aleksandra Kaczmarek
Introduction: This review paper aims to verify the safety of monacolin K, examine the effect on blood cholesterol levels, discuss the contribution to the reduction of cardiovascular risk and indicate examples of pleiotropic effects of this substance. Materials and methods: A review of chosen literature in the PubMed database was conducted, using the following key words: ,,Monacolin K”, ,,Hypercholesterolemia’’, ,,Red yeast rice’’, ,,Supplementation’’. Summary: Monacolin K is considered to be natural statin contained in fermented red rice or oyster mushroom. The use of monacolin K may contribute to the development of mild muscle pain or rhabdomyolysis, but it is noticed less frequently than in treatment with synthetic statins. In addition, there are also concerns about liver and/or kidney damage, headaches and/or dizziness, musculoskeletal symptoms and gastrointestinal disturbances in some people, especially when high doses of monacolin K are used. Monacolin K lowers the level of cholesterol in the blood and contributes to reducing the risk of cardiovascular diseases. Furthermore, monacolin K has anti-inflammatory effects and anti-cancer mechanisms. Conclusions: Monacolin K improves the lipid profile by lowering low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and total cholesterol (TC) levels which indirectly reduces the cardiovascular risk with less frequently observed side effects. Monacolin K has many pleiotropic effects like anti-inflammatory and anti-cancer mechanisms by inhibiting cancer cell proliferation and stimulating apoptosis. It should be emphasized that the long-term safety of regular use of these preparations has not been fully documented. Some people taking these supplements experience side effects similar to those seen with statins. Both health benefits and side effects should be further investigated in future studies.